Artemin Antibody (RM0074-6G32) [Allophycocyanin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-21701APC
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Mouse
Applications
Immunohistochemistry, Immunohistochemistry-Frozen, Western Blot
Label
Allophycocyanin (Excitation = 620-650 nm, Emission = 660-670 nm)
Antibody Source
Monoclonal Rat IgG2 Clone # RM0074-6G32
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Artemin Antibody (RM0074-6G32) [Allophycocyanin]
Immunogen
Mouse recombinant Artemin
Clonality
Monoclonal
Host
Rat
Isotype
IgG2
Applications for Artemin Antibody (RM0074-6G32) [Allophycocyanin]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Immunohistochemistry-Frozen
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Artemin
Alternate Names
ARTN, Enovin, EVN, Neublastin
Gene Symbol
ARTN
Additional Artemin Products
Product Documents for Artemin Antibody (RM0074-6G32) [Allophycocyanin]
Product Specific Notices for Artemin Antibody (RM0074-6G32) [Allophycocyanin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...